Suomi -
suomi -
Fimea (Suomen lääkevirasto)
methylphenidate stada 27 mg depottabletti
stada arzneimittel ag - methylphenidate hydrochloride - depottabletti - 27 mg - metyylifenidaatti
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
methylphenidate stada 18 mg depottabletti
stada arzneimittel ag - methylphenidate hydrochloride - depottabletti - 18 mg - metyylifenidaatti
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
methylphenidate orion 36 mg depottabletti
orion corporation - methylphenidate hydrochloride - depottabletti - 36 mg - metyylifenidaatti
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
methylphenidate orion 27 mg depottabletti
orion corporation - methylphenidate hydrochloride - depottabletti - 27 mg - metyylifenidaatti
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
methylphenidate mylan 54 mg depottabletti
methylphenidate hydrochloride - depottabletti - 54 mg - metyylifenidaatti